AIRBUS SE (AIR.PA)

Executive Summary

Airbus shares declined 2.29% to $169.94 since the June 1st report, extending the downward trajectory and reaching new YTD lows. The latest selloff was triggered by Bloomberg reports that China deliberately stalled aircraft approvals for several months to pressure European regulators on COMAC C919 certification, revealing the geopolitical vulnerability in Airbus's largest delivery market. While management claims the issue is resolved, the episode underscores execution risks across multiple fronts—China delivery uncertainty, A350 production delays, and aggressive A220 production ramp-up requirements—that continue to pressure the investment thesis.

Key Updates

Airbus shares fell 2.29% to $169.94, marking a new YTD low and confirming the breakdown below the $173 support level identified in previous reports. The decline was driven by Bloomberg reports revealing China's Civil Aviation Administration deliberately delayed Airbus aircraft approvals for several months as leverage to expedite COMAC C919 certification in Europe. This forced Airbus to accumulate approximately €5 billion ($5.82 billion) in inventory during Q1 2026—significantly exceeding prior-year levels—and contributed to the company delivering the fewest commercial jets in Q1 since 2009. CEO Guillaume Faury stated in late April that the issue had been resolved with deliveries resuming in Q2, though the revelation of China's tactics introduces new uncertainty around the company's largest single market. The stock has now declined 14.34% YTD, underperforming broader European equity indices and reflecting mounting concerns over execution across multiple production programs.

Current Trend

Airbus has established a clear downtrend in 2026, declining 14.34% YTD to $169.94 and breaking through multiple support levels. The stock experienced a brief recovery from mid-May lows following the A350 delay announcement, rallying from approximately $166 to $177.50 by May 27th. However, this bounce proved unsustainable, with shares declining 4.3% over the past week to new YTD lows. The $173 level, which served as support during the May recovery, has now become resistance. Short-term momentum indicators remain negative across all timeframes: -1.59% daily, -2.16% weekly, -3.54% monthly, and -14.22% over six months. The consistent selling pressure reflects deteriorating sentiment around execution challenges, geopolitical risks, and production bottlenecks that compound rather than resolve over time.

Investment Thesis

The investment thesis for Airbus centers on capturing structural growth in commercial aviation demand through market share gains, production ramp-ups across key platforms (A320neo family, A350, A220), and operational leverage as supply chain constraints ease. The company's strong order book—evidenced by the $19 billion AirAsia A220 order—demonstrates sustained airline demand and positions Airbus for multi-year revenue growth. However, execution has become the critical variable. The thesis depends on Airbus successfully navigating three concurrent challenges: resolving geopolitical delivery risks in China (representing approximately 20% of commercial aircraft deliveries), addressing A350 production bottlenecks at the recently acquired Spirit AeroSystems facility, and ramping A220 production to 13 units monthly by 2028 to achieve program profitability. The company maintains its 2026 delivery target of approximately 870 commercial aircraft, but confidence in execution has diminished significantly given Q1's historic delivery shortfall.

Thesis Status

The investment thesis is materially weakening. While demand fundamentals remain intact—as evidenced by the substantial AirAsia order—execution risks have intensified across all major growth drivers. The China delivery stall, though reportedly resolved, exposed Airbus's vulnerability to geopolitical leverage and resulted in €5 billion in excess inventory accumulation during Q1. The A350 delays stemming from staffing issues at the North Carolina Spirit facility directly threaten the company's goal of doubling production to 12 units by 2028, undermining a key pillar of the growth thesis. The A220 program, while securing major orders, faces pressure to accelerate production beyond planned rates to achieve profitability—a challenging proposition given industry-wide labor constraints. Most concerning is the sequential nature of these issues: rather than resolving previous challenges, Airbus continues to encounter new execution bottlenecks. The 14.34% YTD decline reflects market recognition that operational leverage and margin expansion—central to the bull case—will materialize later and more gradually than previously anticipated. The thesis remains valid long-term but requires significant de-risking through demonstrated execution improvement.

Key Drivers

Three primary factors are driving current performance. First, China's deliberate stalling of aircraft approvals to pressure European regulators on COMAC C919 certification reveals the geopolitical vulnerability in Airbus's business model. Approximately 20 aircraft destined for China remained undelivered, forcing €5 billion in inventory accumulation and contributing to Q1 2026 marking the weakest delivery quarter since 2009. While management claims resolution, EASA's ongoing C919 test flights suggest China may retain this leverage mechanism. Second, A350 production delays stemming from staffing issues at the Spirit AeroSystems facility in North Carolina threaten the production doubling target to 12 units by 2028. The delays compound the previously announced A350 freighter postponement to H2 2027, creating cascading effects on revenue recognition and cash flow generation. Third, the $19 billion AirAsia A220 order, while strategically significant, places pressure on Airbus to accelerate production beyond the planned 13 monthly units by 2028 to achieve program profitability. Industry analysts note AirAsia negotiated significant discounts, suggesting margin pressure on incremental orders. These three drivers collectively highlight execution risk as the dominant near-term theme, overshadowing strong underlying demand fundamentals.

Technical Analysis

Airbus shares are in a confirmed downtrend, trading at $169.94 and establishing new YTD lows. The stock broke below the $173 support level that held during the late-May recovery, confirming the failure of that bounce attempt. The next technical support level sits near $166, representing the intraday lows from the initial A350 delay selloff in mid-May. Resistance has now formed at $173-$175, previously a support zone. The 14.34% YTD decline has accelerated in recent weeks, with all short-term momentum indicators negative: -1.59% daily, -2.16% over five days, and -3.54% over one month. The six-month decline of 14.22% closely mirrors the YTD performance, indicating sustained selling pressure throughout 2026 rather than a single event-driven drop. Volume patterns suggest institutional distribution, with selling pressure intensifying on negative news catalysts. The technical structure indicates further downside risk toward the $160-$166 range unless the company delivers concrete evidence of execution improvement, particularly regarding Q2 China deliveries and A350 production stabilization.

Bull Case

• Substantial order book growth with $19 billion AirAsia commitment: The 150-aircraft A220 order from AirAsia, potentially expanding to $38 billion with A220-500 development, demonstrates robust airline demand and secures multi-year production visibility for the Canadian facility, strengthening Airbus's position in the 100-150 seat market segment against Boeing and Embraer competitors.
• China delivery resolution enabling Q2 catch-up: CEO Guillaume Faury's statement that the China approval issue has been resolved with undelivered planes shipping in Q2 suggests Airbus can recover the 20-aircraft delivery shortfall and reduce the €5 billion inventory accumulation, potentially enabling the company to meet its 870-aircraft full-year target and generate significant cash flow in H2 2026.
• A220 production ramp-up driving program profitability: Airbus's plan to increase A220 production to 12 units monthly by 2026 and 13 monthly by 2028 positions the program to achieve profitability through scale economies, with the substantial AirAsia order providing volume certainty to justify continued production investments in the Mirabel facility.
• Maintained full-year delivery guidance demonstrates management confidence: Despite Q1 marking the fewest commercial jet deliveries since 2009, Airbus has maintained its target of approximately 870 commercial aircraft deliveries for 2026, indicating management visibility into resolution of temporary bottlenecks and confidence in H2 production acceleration.
• Valuation compression creating entry opportunity: The 14.34% YTD decline to $169.94 has compressed Airbus's valuation despite intact long-term aviation demand fundamentals, potentially offering attractive entry points for investors with conviction in the company's ability to resolve near-term execution challenges and capture structural industry growth over a multi-year horizon.

Bear Case

• Geopolitical leverage risk in China market exposed: China's deliberate stalling of aircraft approvals to pressure COMAC C919 certification in Europe reveals Airbus's vulnerability to political interference in its largest single market, with approximately 20 aircraft held in inventory and €5 billion in working capital tied up during Q1—a leverage mechanism China can reactivate at any time to extract commercial or political concessions.
• A350 production delays threatening 2028 targets: Staffing issues at the recently acquired Spirit AeroSystems facility in North Carolina are causing A350 delivery delays later this decade, with Jefferies analysts noting this creates additional challenges for Airbus's goal of doubling A350 production to 12 units by 2028—directly threatening revenue growth assumptions and operational leverage expectations central to the investment thesis.
• Historic Q1 delivery shortfall indicating systemic execution problems: Airbus delivered the fewest commercial jets in Q1 since 2009, suggesting execution challenges extend beyond isolated issues to systemic production and supply chain problems that may require multiple quarters to resolve, with inventory accumulation of €5 billion significantly exceeding prior-year levels and pressuring cash flow generation.
• A220 profitability pressure from discounted pricing: While the $19 billion AirAsia order provides volume certainty, industry analysts note the airline negotiated significant price discounts, placing pressure on Airbus to accelerate production beyond planned rates to improve program economics—a challenging proposition given industry-wide labor constraints and the program's ongoing path to profitability since acquisition from Bombardier in 2018.
• Cascading delays across multiple programs undermining confidence: The combination of A350 delivery delays, postponement of the A350 freighter to H2 2027, and broader supply chain disruption indicates Airbus faces interconnected execution challenges rather than isolated issues, with each delay creating downstream effects on customer relationships, cash flow timing, and the company's ability to meet ambitious production ramp-up targets across its commercial aircraft portfolio.